Metraipolis › archive › dc_08b6877ec45d
Rinat Neuroscience Corporation — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-15T18:30:19.449Z
- SHA-256 of the archived text
88b204fa125f1a6958bdeafe714c93fa7853ec3b6e3d8ba6625119dc5b65f908- Stable URL of this page
https://metraipolis.com/documento/dc_08b6877ec45d
How to cite
Rinat Neuroscience Corporation — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_08b6877ec45d (Metraipolis archive dc_08b6877ec45d, sha256 88b204fa125f1a6958bdeafe714c93fa7853ec3b6e3d8ba6625119dc5b65f908)
BibTeX
@misc{dc08b6877ec45d,
title = {Rinat Neuroscience Corporation — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_08b6877ec45d; sha256 88b204fa125f1a6958bdeafe714c93fa7853ec3b6e3d8ba6625119dc5b65f908},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Rinat Neuroscience Corporation was a privately held biotechnology company that discovered and developed antibody-based drugs, including: Tanezumab (codenamed RN624), a monoclonal antibody against nerve growth factor for the treatment of pain Ponezumab (codenamed RN1219), a monoclonal antibody against beta amyloid for the treatment of Alzheimer's disease Fremanezumab (codenamed TEV-48125, RN307 and LBR-101), a monoclonal antibody against calcitonin gene-related peptide for the treatment of migraines Bococizumab (codenamed RN316), a monoclonal antibody against PCSK9 designed to reduce LDL cholesterol RN6G, a monoclonal antibody against beta amyloid for the treatment of geographic atrophy in age-related macular degeneration RN909, a monoclonal antibody antagonist of the glucagon receptor for type 2 diabetes (T2DM) REGN4018, a novel MUC16xCD3 bispecific T-cell engager for the treatment of ovarian cancer PF-04518600, a monoclonal antibody targeting OX40 to enhance T cell functions and inhibit tumor growth Rinat was founded in 2001 by Arnon Rosenthal, who was also Rinat's president, chief scientific office and board director, and Patrick Lynn, following a broad licensing agreement with Genentech, and was acquired by Pfizer in 2006 for approximately $500M. Rinat currently operates as an independent biotechnology unit within Pfizer's Worldwide R&D group in South San Francisco. Tema degli esploratori: scienze della vita e salute (deposito sistematico; ricerca «neuroscience»). Fonte: Wikipedia in inglese, voce «Rinat Neuroscience Corporation» — https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation Wikidata Q18390439 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q18390439 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Rinat_Neuroscience_Corporation?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1226450776, consultata il 2026-10-15T17:57:53.258Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 39a84c0816764dbe0e70daa77022df52ce83807dc5304aa5922b7dc18c0c81f0